NanoString Technologies Inc (NSTG) Insider Sells $16,800.00 in Stock

NanoString Technologies Inc (NASDAQ:NSTG) insider R Bradley Gray sold 60,000 shares of NanoString Technologies stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $0.28, for a total transaction of $16,800.00. Following the completion of the sale, the insider now owns 77,130 shares of the company’s stock, valued at $21,596.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

R Bradley Gray also recently made the following trade(s):

  • On Friday, February 1st, R Bradley Gray sold 20,000 shares of NanoString Technologies stock. The shares were sold at an average price of $22.28, for a total transaction of $445,600.00.
  • On Wednesday, January 9th, R Bradley Gray sold 30,000 shares of NanoString Technologies stock. The shares were sold at an average price of $20.04, for a total transaction of $601,200.00.

NASDAQ:NSTG traded up $0.80 during mid-day trading on Friday, reaching $27.51. The stock had a trading volume of 782,386 shares, compared to its average volume of 444,068. The stock has a market capitalization of $862.30 million, a price-to-earnings ratio of -9.90 and a beta of 1.32. The company has a debt-to-equity ratio of 1.58, a current ratio of 3.05 and a quick ratio of 3.22. NanoString Technologies Inc has a 12 month low of $6.30 and a 12 month high of $31.14.

NanoString Technologies (NASDAQ:NSTG) last announced its quarterly earnings data on Thursday, March 7th. The biotechnology company reported ($0.68) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.50) by ($0.18). The firm had revenue of $30.03 million during the quarter. NanoString Technologies had a negative net margin of 72.52% and a negative return on equity of 252.59%. As a group, analysts anticipate that NanoString Technologies Inc will post -2.43 EPS for the current fiscal year.

A number of brokerages recently issued reports on NSTG. ValuEngine raised shares of NanoString Technologies from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, January 2nd. BidaskClub raised shares of NanoString Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, January 5th. Zacks Investment Research raised shares of NanoString Technologies from a “hold” rating to a “buy” rating and set a $20.00 price objective on the stock in a research note on Thursday, January 10th. Finally, JPMorgan Chase & Co. reissued an “overweight” rating and issued a $35.00 price objective on shares of NanoString Technologies in a research note on Friday, March 8th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. NanoString Technologies presently has an average rating of “Buy” and an average price target of $22.80.

A number of large investors have recently made changes to their positions in the stock. Geode Capital Management LLC increased its stake in NanoString Technologies by 11.6% in the fourth quarter. Geode Capital Management LLC now owns 334,841 shares of the biotechnology company’s stock valued at $4,964,000 after acquiring an additional 34,717 shares during the last quarter. Millennium Management LLC grew its stake in shares of NanoString Technologies by 51.0% during the fourth quarter. Millennium Management LLC now owns 353,432 shares of the biotechnology company’s stock worth $5,241,000 after buying an additional 119,428 shares during the last quarter. Metropolitan Life Insurance Co. NY grew its stake in shares of NanoString Technologies by 430.9% during the fourth quarter. Metropolitan Life Insurance Co. NY now owns 8,893 shares of the biotechnology company’s stock worth $132,000 after buying an additional 7,218 shares during the last quarter. Squarepoint Ops LLC grew its stake in shares of NanoString Technologies by 134.9% during the fourth quarter. Squarepoint Ops LLC now owns 50,259 shares of the biotechnology company’s stock worth $745,000 after buying an additional 28,859 shares during the last quarter. Finally, Two Sigma Advisers LP grew its stake in shares of NanoString Technologies by 30.4% during the fourth quarter. Two Sigma Advisers LP now owns 66,900 shares of the biotechnology company’s stock worth $992,000 after buying an additional 15,600 shares during the last quarter. 88.65% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “NanoString Technologies Inc (NSTG) Insider Sells $16,800.00 in Stock” was published by WKRB News and is the property of of WKRB News. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.wkrb13.com/2019/03/15/nanostring-technologies-inc-nstg-insider-sells-16800-00-in-stock.html.

NanoString Technologies Company Profile

NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.

Featured Story: Capital Gains

Insider Buying and Selling by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply